Evidence is mounting that GLP-1 drugs may play a role in reducing cancer risk and deaths from certain cancers.

Ibuprofen’s anti-inflammatory action may influence cancer risk, but evidence remains complex and routine use for prevention is not advised. Ibuprofen is one of the most widely used pain relievers, ...

Dr Dana Chase describes how structural disparities and prior minimized care delay diagnosis and erode trust, requiring ...

Dr Dana Chase recalls early-career experiences and describes how revolutionary advances in surgery and personalized medicine ...

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...

We’re starting to understand more that endometrial cancer harbors a number of cell surface markers, including folate receptor ...

After years of debilitating pain and countless meetings with specialists, a young patient shares how she finally got ...

The five-year relative survival for all cancers combined has reached a milestone, according to the American Cancer Society.

NP-G2-044 (Prilukae), a novel oral fascin inhibitor, has earned orphan drug designation (ODD) from the FDA for the treatment ...

While rates of cancer diagnosis under age 50 have risen in recent years, this has not translated into increased cancer ...

Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...